WCC_Connect_MDS/AML

CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY

The purpose of the Connect MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed MDS, ICUS, or AML in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.
N/A
NCT01688011
Cancer
Hematologic
James Cunningham, M.D.
Celgene Corporation
Cheryl Dodd
  • Providence St. Mary Regional Cancer Center
  • Walla Walla Research